Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025)

Treace Medical Concepts' Asset Writedowns and Impairment history spans 6 years, with the latest figure at -$69000.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 139.66% year-over-year to -$69000.0; the TTM value through Sep 2025 reached -$1.9 million, down 169.17%, while the annual FY2023 figure was $400000.0, 2.68% down from the prior year.
  • Asset Writedowns and Impairment reached -$69000.0 in Q3 2025 per TMCI's latest filing, down from $81000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.0 million in Q2 2024 to a low of -$2.4 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $74176.5, with a median of $38000.0 recorded in 2023.
  • The largest YoY upside for Asset Writedowns and Impairment was 17300.0% in 2024 against a maximum downside of 841.74% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$35000.0 in 2021, then soared by 1382.86% to $449000.0 in 2022, then decreased by 28.51% to $321000.0 in 2023, then plummeted by 841.74% to -$2.4 million in 2024, then skyrocketed by 97.1% to -$69000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Asset Writedowns and Impairment are -$69000.0 (Q3 2025), $81000.0 (Q2 2025), and $500000.0 (Q1 2025).